Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: European Pharmacopoeia monograph | Statement: [Certificates of Suitability to the monographs of the European Pharmacopoeia, confirmsComplianceWith, European Pharmacopoeia monograph]

Target entity: European Pharmacopoeia monograph
Context triple: [Certificates of Suitability to the monographs of the European Pharmacopoeia, confirmsComplianceWith, European Pharmacopoeia monograph]

• A. European Pharmacopoeia chosen
  The European Pharmacopoeia is a legally binding reference work that sets quality standards for medicines and their ingredients across member states of the Council of Europe.
• B. Certificates of Suitability to the monographs of the European Pharmacopoeia
  Certificates of Suitability to the monographs of the European Pharmacopoeia are official documents issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) confirming that a substance’s quality complies with the relevant European Pharmacopoeia monograph, thereby simplifying regulatory approval for medicines across Europe.
• C. United States Pharmacopeia
  The United States Pharmacopeia is an official compendium that sets quality, purity, strength, and identity standards for medicines, food ingredients, and dietary supplements used in the United States and many other countries.
• D. Japanese Pharmacopoeia
  The Japanese Pharmacopoeia is Japan’s official compendium of drug quality standards, specifications, and testing methods that ensures the safety and efficacy of medicines used in the country.
• E. ICH Q3A Impurities in New Drug Substances
  ICH Q3A Impurities in New Drug Substances is an international regulatory guideline that sets quality standards and thresholds for identifying, reporting, and controlling impurities in new active pharmaceutical ingredients.
• F. None of above.
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target predicate: confirmsComplianceWith
Context triple: [Certificates of Suitability to the monographs of the European Pharmacopoeia, confirmsComplianceWith, European Pharmacopoeia monograph]

• A. indicatesComplianceWith chosen
  Indicates that one entity conforms to, satisfies, or adheres to the rules, standards, or requirements specified by another entity or framework.
• B. providesCompliance
  Indicates that one entity supplies or ensures adherence to required rules, standards, or regulations for another entity.
• C. evaluatesComplianceWith
  Indicates that one entity assesses whether another entity or its behavior meets specified rules, standards, or requirements.
• D. regulatesComplianceWith
  Indicates that one entity oversees, enforces, or sets rules to ensure another entity adheres to specified standards, laws, or requirements.
• E. hasComplianceStatement
  Indicates that an entity is associated with a formal declaration that it adheres to specified rules, standards, or regulatory requirements.
• F. None of above.